https://www.ajmc.com/view/patients-with-hfref-hfpef-see-different-functional-capacity-benefits-with-dapagliflozin
0
0
12/7/23 at 7:09pm
Organization
Ajmc.com
Author
Hayden E. Klein
47 words
0
Comments
The DETERMINE-Reduced and DETERMINE-Preserved trials demonstrated varying benefits of dapagliflozin on Kansas City Cardiomyopathy Questionnaire Total Symptom Score and Physical Limitation Scale as well as 6-minute walk distance.
You are the first to view
Create an account
or login to join the discussion